|
1
|
zur Hausen H: Papillomaviruses in the
causation of human cancers - a brief historical account. Virology.
384:260–265. 2009. View Article : Google Scholar
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Smith JS, Lindsay L, Hoots B, Keys J,
Franceschi S, Winer R and Clifford GM: Human papillomavirus type
distribution in invasive cervical cancer and high-grade cervical
lesions: A meta-analysis update. Int J Cancer. 121:621–632. 2007.
View Article : Google Scholar
|
|
4
|
Riley RR, Duensing S, Brake T, Münger K,
Lambert PF and Arbeit JM: Dissection of human papillomavirus E6 and
E7 function in transgenic mouse models of cervical carcinogenesis.
Cancer Res. 63:4862–4871. 2003.
|
|
5
|
Brake T and Lambert PF: Estrogen
contributes to the onset, persistence, and malignant progression of
cervical cancer in a human papillomavirus-transgenic mouse model.
Proc Natl Acad Sci USA. 102:2490–2495. 2005. View Article : Google Scholar
|
|
6
|
Chung SH, Wiedmeyer K, Shai A, Korach KS
and Lambert PF: Requirement for estrogen receptor alpha in a mouse
model for human papillomavirus-associated cervical cancer. Cancer
Res. 68:9928–9934. 2008. View Article : Google Scholar
|
|
7
|
Cortés-Malagón EM, Bonilla-Delgado J,
Díaz-Chávez J, Hidalgo-Miranda A, Romero-Cordoba S, Uren A, Celik
H, McCormick M, Munguía-Moreno JA, Ibarra-Sierra E, et al: Gene
expression profile regulated by the HPV16 E7 oncoprotein and
estradiol in cervical tissue. Virology. 447:155–165. 2013.
View Article : Google Scholar
|
|
8
|
Nickens KP, Han Y, Shandilya H, Larrimore
A, Gerard GF, Kaldjian E, Patierno SR and Ceryak S: Acquisition of
mitochondrial dysregulation and resistance to
mitochondrial-mediated apoptosis after genotoxic insult in normal
human fibroblasts: A possible model for early stage carcinogenesis.
Biochim Biophys Acta. 1823:264–272. 2012. View Article : Google Scholar
|
|
9
|
Rousalova I and Krepela E: Granzyme
B-induced apoptosis in cancer cells and its regulation (review).
Int J Oncol. 37:1361–1378. 2010.
|
|
10
|
Berthou C, Michel L, Soulié A, Jean-Louis
F, Flageul B, Dubertret L, Sigaux F, Zhang Y and Sasportes M:
Acquisition of granzyme B and Fas ligand proteins by human
keratinocytes contributes to epidermal cell defense. J Immunol.
159:5293–5300. 1997.
|
|
11
|
Hernandez-Pigeon H, Jean C, Charruyer A,
Haure MJ, Titeux M, Tonasso L, Quillet-Mary A, Baudouin C,
Charveron M and Laurent G: Human keratinocytes acquire cellular
cytotoxicity under UV-B irradiation. Implication of granzyme B and
perforin J Biol Chem. 281:13525–13532. 2006.
|
|
12
|
Fang Y, Herrick EJ and Nicholl MB: A
possible role for perforin and granzyme B in resveratrol-enhanced
radiosensitivity of prostate cancer. J Androl. 33:752–760. 2012.
View Article : Google Scholar
|
|
13
|
Hernandez-Pigeon H, Jean C, Charruyer A,
Haure MJ, Baudouin C, Charveron M, Quillet-Mary A and Laurent G:
UVA induces granzyme B in human keratinocytes through MIF:
Implication in extracellular matrix remodeling. J Biol Chem.
282:8157–8164. 2007. View Article : Google Scholar
|
|
14
|
Boivin WA, Cooper DM, Hiebert PR and
Granville DJ: Intracellular versus extracellular granzyme B in
immunity and disease: Challenging the dogma. Lab Invest.
89:1195–1220. 2009. View Article : Google Scholar
|
|
15
|
Khan MS, Singh P, Azhar A, Naseem A,
Rashid Q, Kabir MA and Jairajpuri MA: Serpin inhibition mechanism:
A delicate balance between native metastable state and
polymerization. J Amino Acids. 2011:6067972011. View Article : Google Scholar
|
|
16
|
Medema JP, de Jong J, Peltenburg LT,
Verdegaal EM, Gorter A, Bres SA, Franken KL, Hahne M, Albar JP,
Melief CJ, et al: Blockade of the granzyme B/perforin pathway
through overexpression of the serine protease inhibitor PI-9/SPI-6
constitutes a mechanism for immune escape by tumors. Proc Natl Acad
Sci USA. 98:11515–11520. 2001. View Article : Google Scholar
|
|
17
|
Herber R, Liem A, Pitot H and Lambert PF:
Squamous epithelial hyperplasia and carcinoma in mice transgenic
for the human papillomavirus type 16 E7 oncogene. J Virol.
70:1873–1881. 1996.
|
|
18
|
Ibarra Sierra E, Díaz Chávez J,
Cortés-Malagón EM, Uribe-Figueroa L, Hidalgo-Miranda A, Lambert PF
and Gariglio P: Differential gene expression between skin and
cervix induced by the E7 oncoprotein in a transgenic mouse model.
Virology. 433:337–345. 2012. View Article : Google Scholar
|
|
19
|
Kendziorski C, Irizarry RA, Chen KS, Haag
JD and Gould MN: On the utility of pooling biological samples in
microarray experiments. Proc Natl Acad Sci USA. 102:4252–4257.
2005. View Article : Google Scholar
|
|
20
|
Chabas D, Baranzini SE, Mitchell D,
Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M,
Pedotti R, et al: The influence of the proinflammatory cytokine,
osteopontin, on autoimmune demyelinating disease. Science.
294:1731–1735. 2001. View Article : Google Scholar
|
|
21
|
Kainkaryam RM, Bruex A, Gilbert AC,
Schiefelbein J and Woolf PJ: poolMC: Smart pooling of mRNA samples
in microarray experiments. BMC Bioinformatics. 11:2992010.
View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
23
|
McLaughlin-Drubin ME, Crum CP and Münger
K: Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B
histone demethylase expression and causes epigenetic reprogramming.
Proc Natl Acad Sci USA. 108:2130–2135. 2011. View Article : Google Scholar
|
|
24
|
McLaughlin-Drubin ME, Park D and Munger K:
Tumor suppressor p16INK4A is necessary for survival of
cervical carcinoma cell lines. Proc Natl Acad Sci USA.
110:16175–16180. 2013. View Article : Google Scholar
|
|
25
|
Yim EK and Park JS: Biomarkers in cervical
cancer. Biomark Insights. 1:215–225. 2007.
|
|
26
|
Chung SH, Franceschi S and Lambert PF:
Estrogen and ERalpha: Culprits in cervical cancer. Trends
Endocrinol Metab. 21:504–511. 2010. View Article : Google Scholar
|
|
27
|
den Boon JA, Pyeon D, Wang SS, Horswill M,
Schiffman M, Sherman M, Zuna RE, Wang Z, Hewitt SM, Pearson R, et
al: Molecular transitions from papillomavirus infection to cervical
precancer and cancer: Role of stromal estrogen receptor signaling.
Proc Natl Acad Sci USA. 112:E3255–E3264. 2015. View Article : Google Scholar
|
|
28
|
Dozmorov MG, Giles CB and Wren JD:
Predicting gene ontology from a global meta-analysis of 1-color
microarray experiments. BMC Bioinformatics. 12(Suppl 10): S142011.
View Article : Google Scholar
|
|
29
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View Article : Google Scholar
|
|
30
|
Zhang F and Du G: Dysregulated lipid
metabolism in cancer. World J Biol Chem. 3:167–174. 2012.
View Article : Google Scholar
|
|
31
|
Menendez JA and Lupu R: Fatty acid
synthase and the lipogenic phenotype in cancer pathogenesis. Nat
Rev Cancer. 7:763–777. 2007. View Article : Google Scholar
|
|
32
|
Röhrig F and Schulze A: The multifaceted
roles of fatty acid synthesis in cancer. Nat Rev Cancer.
16:732–749. 2016. View Article : Google Scholar
|
|
33
|
Baenke F, Peck B, Miess H and Schulze A:
Hooked on fat: The role of lipid synthesis in cancer metabolism and
tumour development. Dis Model Mech. 6:1353–1363. 2013. View Article : Google Scholar
|
|
34
|
Henderson BE, Ross RK, Pike MC and
Casagrande JT: Endogenous hormones as a major factor in human
cancer. Cancer Res. 42:3232–3239. 1982.
|
|
35
|
Furth J: A meeting of ways in cancer
research: Thoughts on the evolution and nature of neoplasms. Cancer
Res. 19:241–258. 1959.
|
|
36
|
Arbeit JM, Howley PM and Hanahan D:
Chronic estrogen-induced cervical and vaginal squamous
carcinogenesis in human papillomavirus type 16 transgenic mice.
Proc Natl Acad Sci USA. 93:2930–2935. 1996. View Article : Google Scholar
|
|
37
|
Nielsen SJ, Gøtze JP, Jensen HL and
Rehfeld JF: ProCNP and CNP are expressed primarily in male genital
organs. Regul Pept. 146:204–212. 2008. View Article : Google Scholar
|
|
38
|
Nielsen SJ, Iversen P, Rehfeld JF, Jensen
HL and Goetze JP: C-type natriuretic peptide in prostate cancer.
APMIS. 117:60–67. 2009. View Article : Google Scholar
|
|
39
|
Scotland RS, Ahluwalia A and Hobbs AJ:
C-type natriuretic peptide in vascular physiology and disease.
Pharmacol Ther. 105:85–93. 2005. View Article : Google Scholar
|
|
40
|
Grinde MT, Skrbo N, Moestue SA, Rødland
EA, Borgan E, Kristian A, Sitter B, Bathen TF, Børresen-Dale AL,
Mælandsmo GM, et al: Interplay of choline metabolites and genes in
patient-derived breast cancer xenografts. Breast Cancer Res.
16:R52014. View Article : Google Scholar
|
|
41
|
Demichelis F, Setlur SR, Banerjee S,
Chakravarty D, Chen JY, Chen CX, Huang J, Beltran H, Oldridge DA,
Kitabayashi N, et al: Identification of functionally active, low
frequency copy number variants at 15q21.3 and 12q21.31 associated
with prostate cancer risk. Proc Natl Acad Sci USA. 109:6686–6691.
2012. View Article : Google Scholar
|
|
42
|
Mar AC, Chu CH, Lee HJ, Chien CW, Cheng
JJ, Yang SH, Jiang JK and Lee TC: Interleukin-1 receptor type 2
acts with c-Fos to enhance the expression of interleukin-6 and
vascular endothelial growth factor A in colon cancer cells and
induce angiogenesis. J Biol Chem. 290:22212–22224. 2015. View Article : Google Scholar
|
|
43
|
Amann PM, Czaja K, Bazhin AV, Rühl R,
Eichmüller SB, Merk HF and Baron JM: LRAT overexpression diminishes
intracellular levels of biologically active retinoids and reduces
retinoid antitumor efficacy in the murine melanoma B16F10 cell
line. Skin Pharmacol Physiol. 28:205–212. 2015. View Article : Google Scholar
|
|
44
|
Hiebert PR and Granville DJ: Granzyme B in
injury, inflammation, and repair. Trends Mol Med. 18:732–741. 2012.
View Article : Google Scholar
|
|
45
|
Provenzano PP, Inman DR, Eliceiri KW,
Knittel JG, Yan L, Rueden CT, White JG and Keely PJ: Collagen
density promotes mammary tumor initiation and progression. BMC Med.
6:112008. View Article : Google Scholar
|
|
46
|
Saito S, Murakoshi K, Kotake S, Kamatani N
and Tomatsu T: Granzyme B induces apoptosis of chondrocytes with
natural killer cell-like cytotoxicity in rheumatoid arthritis. J
Rheumatol. 35:1932–1943. 2008.
|
|
47
|
Parkinson LG, Toro A, Zhao H, Brown K,
Tebbutt SJ and Granville DJ: Granzyme B mediates both direct and
indirect cleavage of extracellular matrix in skin after chronic
low-dose ultraviolet light irradiation. Aging Cell. 14:67–77. 2015.
View Article : Google Scholar
|
|
48
|
Meyaard L: The inhibitory collagen
receptor LAIR-1 (CD305). J Leukoc Biol. 83:799–803. 2008.
View Article : Google Scholar
|
|
49
|
Vesely MD, Kershaw MH, Schreiber RD and
Smyth MJ: Natural innate and adaptive immunity to cancer. Annu Rev
Immunol. 29:235–271. 2011. View Article : Google Scholar
|
|
50
|
Salmon H, Franciszkiewicz K, Damotte D,
Dieu-Nosjean MC, Validire P, Trautmann A, Mami-Chouaib F and
Donnadieu E: Matrix architecture defines the preferential
localization and migration of T cells into the stroma of human lung
tumors. J Clin Invest. 122:899–910. 2012. View Article : Google Scholar
|
|
51
|
Sorokin L: The impact of the extracellular
matrix on inflammation. Nat Rev Immunol. 10:712–723. 2010.
View Article : Google Scholar
|
|
52
|
Weathington NM, van Houwelingen AH,
Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G,
Nijkamp FP and Blalock JE: A novel peptide CXCR ligand derived from
extracellular matrix degradation during airway inflammation. Nat
Med. 12:317–323. 2006. View
Article : Google Scholar
|
|
53
|
Jadhav RR, Ye Z, Huang RL, Liu J, Hsu PY,
Huang YW, Rangel LB, Lai HC, Roa JC, Kirma NB, et al: Genome-wide
DNA methylation analysis reveals estrogen-mediated epigenetic
repression of metallothionein-1 gene cluster in breast cancer. Clin
Epigenetics. 7:132015. View Article : Google Scholar
|
|
54
|
Laurson J, Khan S, Chung R, Cross K and
Raj K: Epigenetic repression of E-cadherin by human papillomavirus
16 E7 protein. Carcinogenesis. 31:918–926. 2010. View Article : Google Scholar
|
|
55
|
McLane LM, Banerjee PP, Cosma GL,
Makedonas G, Wherry EJ, Orange JS and Betts MR: Differential
localization of T-bet and Eomes in CD8 T cell memory populations. J
Immunol. 190:3207–3215. 2013. View Article : Google Scholar
|
|
56
|
Fukuoka N, Harada M, Nishida A, Ito Y,
Shiota H and Kataoka T: Eomesodermin promotes interferon-γ
expression and binds to multiple conserved noncoding sequences
across the Ifng locus in mouse thymoma cell lines. Genes Cells.
21:146–162. 2016. View Article : Google Scholar
|
|
57
|
Banno T, Adachi M, Mukkamala L and
Blumenberg M: Unique keratinocyte-specific effects of
interferon-gamma that protect skin from viruses, identified using
transcriptional profiling. Antivir Ther. 8:541–554. 2003.
|
|
58
|
Black AP, Ardern-Jones MR, Kasprowicz V,
Bowness P, Jones L, Bailey AS and Ogg GS: Human keratinocyte
induction of rapid effector function in antigen-specific memory
CD4+ and CD8+ T cells. Eur J Immunol.
37:1485–1493. 2007. View Article : Google Scholar
|
|
59
|
Soriano C, Mukaro V, Hodge G, Ahern J,
Holmes M, Jersmann H, Moffat D, Meredith D, Jurisevic C, Reynolds
PN, et al: Increased proteinase inhibitor-9 (PI-9) and reduced
granzyme B in lung cancer: Mechanism for immune evasion. Lung
Cancer. 77:38–45. 2012. View Article : Google Scholar
|
|
60
|
Bird CH, Sutton VR, Sun J, Hirst CE, Novak
A, Kumar S, Trapani JA, Bird PI, et al: Selective regulation of
apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9
protects against granzyme B-mediated apoptosis without perturbing
the Fas cell death pathway. Mol Cell Biol. 18:6387–6398. 1998.
View Article : Google Scholar
|
|
61
|
Buzza MS, Hirst CE, Bird CH, Hosking P,
McKendrick J and Bird PI: The granzyme B inhibitor, PI-9, is
present in endothelial and mesothelial cells, suggesting that it
protects bystander cells during immune responses. Cell Immunol.
210:21–29. 2001. View Article : Google Scholar
|
|
62
|
Barrie MB, Stout HW, Abougergi MS, Miller
BC and Thiele DL: Antiviral cytokines induce hepatic expression of
the granzyme B inhibitors, proteinase inhibitor 9 and serine
proteinase inhibitor 6. J Immunol. 172:6453–6459. 2004. View Article : Google Scholar
|
|
63
|
Jiang X, Orr BA, Kranz DM and Shapiro DJ:
Estrogen induction of the granzyme B inhibitor, proteinase
inhibitor 9, protects cells against apoptosis mediated by cytotoxic
T lymphocytes and natural killer cells. Endocrinology.
147:1419–1426. 2006. View Article : Google Scholar
|
|
64
|
Lauricella M, Carlisi D, Giuliano M,
Calvaruso G, Cernigliaro C, Vento R and D'Anneo A: The analysis of
estrogen receptor-α positive breast cancer stem-like cells unveils
a high expression of the serpin proteinase inhibitor PI-9: Possible
regulatory mechanisms. Int J Oncol. 49:352–360. 2016. View Article : Google Scholar
|
|
65
|
Cunningham TD, Jiang X and Shapiro DJ:
Expression of high levels of human proteinase inhibitor 9 blocks
both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity.
Cell Immunol. 245:32–41. 2007. View Article : Google Scholar
|
|
66
|
Deisting W, Raum T, Kufer P, Baeuerle PA
and Münz M: Impact of diverse immune evasion mechanisms of cancer
cells on T cells engaged by EpCAM/CD3-bispecific antibody construct
AMG 110. PLoS One. 10:e01416692015. View Article : Google Scholar
|
|
67
|
Bladergroen BA, Meijer CJ, ten Berge RL,
Hack CE, Muris JJ, Dukers DF, Chott A, Kazama Y, Oudejans JJ, van
Berkum O, et al: Expression of the granzyme B inhibitor, protease
inhibitor 9, by tumor cells in patients with non-Hodgkin and
Hodgkin lymphoma: A novel protective mechanism for tumor cells to
circumvent the immune system. Blood. 99:232–237. 2002. View Article : Google Scholar
|
|
68
|
Fritsch K, Finke J and Grüllich C:
Suppression of granzyme B activity and caspase-3 activation in
leukaemia cells constitutively expressing the protease inhibitor 9.
Ann Hematol. 92:1603–1609. 2013. View Article : Google Scholar
|
